Even though it is easy to think that our lives are governed by few significant ideas, the reality is actually quite different. In real-world circumstances, we interact with many unique concepts over time. These concepts are, more often than not, responsible for bringing us closer to a part of ourselves, thus fuelling that overall understanding on an individual’s part. Now, when you have such a comprehensive setup in place, it’s always going to result in growth. However, that’s not really the best thing about it. The best part here talks to how the setup allows us to use our enhanced understanding in whichever we want. There are some notable benefits for having this luxury at your disposal, and one that really sticks out is technology. You see, by giving a productive angle to the present expansiveness, we were able to develop something, which complemented our lives like nothing else. In fact, since arriving on the scene, technology has done so in the most unimaginable ways. The creation’s most important bid, though, is still what it did within the medical sector. Using its generational capabilities, technology was successful in establishing a healthcare model that was beyond unprecedented, and yet it has somehow continued to build upon the said achievement. The ongoing progression was on full display during a recent funding round.
ConcertoCare has officially raised $105 million worth of funding in a recently-concluded Series B round. Led by Wells Fargo Strategic Capital, the round also saw close participation from Obvious Ventures, Vast Ventures, The Schusterman Family Foundation, SteelSky Ventures, Pennington Partners and returning investor Deerfield Management. While revealing the funding details, Concerto further went on to share that it has acquired Crown Health, a leading home-based primary care practice serving the Pacific Northwest, for an undisclosed sum. The acquisition, along with fresh funds, gives Concerto every bit of momentum, as it plans on improving the company’s work around clinical outcomes that focus on elderly care. Notably enough, these outcomes can relate to anything such as chronic disease management, access to nutrition meals, and a lot more.
Apart from scaling up in regards to core quality, Concerto also plans on devoting the new funds to facilitate overall expansion. Currently active across Washington, New York, Oregon, Ohio, California, Massachusetts, Virginia, and Florida, the company is reportedly collaborating with value-based health plans for taking its tech-enabled multidisciplinary approach to new US markets.
“These vulnerable patients are too often failed by the traditional American healthcare system, a situation that is frequently exacerbated by health inequities,” said Julian Harris, CEO of ConcertoCare. “Our focus is on building a great company, growing our team, adding new features to and scaling our Patient3D technology platform, and expanding our partnerships and presence to further increase access to Concerto’s model of care.”
